Results 191 to 200 of about 41,693 (234)

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

Vaccines, 2022
Esam Ibraheem Azhar, Naif Khalaf Alharbi, Anwar Hashem   +2 more
exaly  

Comparison of Recombinant MVA Selection Methods Based on F13L, D4R and K1L Genes

Viruses, 2022
German Shipulin, Felix Urusov, Antoshkina I V   +2 more
exaly  

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

Frontiers in Immunology, 2022
Hendrik Jan Thibaut, Johan Neyts, Juan García-Arriaza   +2 more
exaly  

MVA - Variable Selection

2023
Matthias Fengler, Petra Burdejova, Wolfgang Karl Härdle   +2 more
openaire   +1 more source

A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection

Frontiers in Immunology, 2022
Joanna Luczkowiak, JOSÉ M Casasnovas, Juan García-Arriaza   +2 more
exaly  

MVA Factor Analysis

2023
Matthias Fengler, Petra Burdejova, Wolfgang Karl Härdle   +2 more
openaire   +1 more source

The Albany MVA Project.

2004
Edward B. Blanchard, Edward J. Hickling
openaire   +1 more source

MVA p53/pembrolizumab

Reactions Weekly, 2018
openaire   +1 more source

A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS

Vaccine, 2020
Darja Schmidt, Jack Stapleton, Edgar Overton   +2 more
exaly  

Bio-isoprene production using exogenous MVA pathway and isoprene synthase in Escherichia coli

Bioresource Technology, 2012
Mo Xian, Jianming Yang, Xinglin Jiang
exaly